The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 16 rounds in the feed, most often at Series D+ and in Healthtech.
Alpha Wave is an alternative asset manager that operates across private equity, private credit, and insurance and retirement solutions.
Investment firmalphawaveglobal.comRounds from 2021-11-10 to 2026-09-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Cognition Cognition builds Devin, an AI software engineering agent that plans, writes, tests, and ships code for engineering teams. | Series E Verified against 4 of 18 sources | $2.0B | 2026-09-08 | [ PART ] |
Ultrahuman Ultrahuman sells health tracking devices and services, including continuous glucose monitors and performance analytics, primarily for health-conscious consumers. | Funding round |
| $65M |
| 2026-09-03 |
| [ PART ] |
Even Healthcare Even Healthcare provides health insurance solutions, making it easy and transparent for consumers to choose the right policy. | Funding round Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-07-21 | [ PART ] |
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer. | Series D Verified against 4 of 6 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $315M | 2026-07-15 | [ LEAD ] |
Cognition Cognition builds Devin, an AI software engineering agent that plans, writes, tests, and ships code for engineering teams. | Series D Verified against 1 of 5 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.0B | 2026-05-27 | [ PART ] |
Even Healthcare A healthcare startup aiming to change hospital economics in India | Funding round Developing, 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $20M | 2026-01-06 | [ LEAD ] |
Biolinq Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-04-22 | [ LEAD ] |
Even Healthcare Even Healthcare provides health insurance solutions, making it easy and transparent for consumers to choose the right policy. | Series A Verified against 4 of 5 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2024-10-23 | [ PART ] |
HistoSonics HistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2024-08-15 | [ LEAD ] |
Biolinq Biolinq sells wearable biosensor technology that monitors glucose levels for health and metabolic insights. | Bridge Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $58M | 2024-06-02 | [ LEAD ] |
Ultrahuman Ultrahuman sells health tracking devices and services, including continuous glucose monitors and performance analytics, primarily for health-conscious consumers. | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $35M financing total | 2024-03-20 | [ PART ] |
Even Healthcare A healthcare startup aiming to change hospital economics in India | Funding round Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $15M | 2022-11-10 | [ PART ] |
CRED CRED is a membership platform that rewards trustworthy individuals with financial and lifestyle enhancements, focusing on credit card management and exclusive perks. | Series F Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $140M | 2022-06-09 | [ PART ] |
Life Biosciences A biotechnology company focusing on longevity and regenerative medicine | Series C Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $82M | 2022-01-05 | [ LEAD ] |
Monzo Monzo offers personal and business banking services, focusing on current accounts, savings, insurance, loans, and credit cards primarily for UK residents. | Series H ext. Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $475M | 2021-12-08 | [ PART ] |
Cerebras Cerebras sells powerful AI infrastructure solutions, including the Cerebras CS-4, for fast inference and model training aimed at enterprises and developers. | Series F Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $250M | 2021-11-10 | [ LEAD ] |